T. Berghmans

A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesothelioma

T. Berghmans, J.J. Lafitte, Marianne Paesmans et al. · Lung Cancer · 2005 · 25 citations

Medicine, Pathology, Phase Ii Study +5

Leucopenia is an independent predictor in cancer patients requiring invasive mechanical ventilation: a prognostic factor analysis in a series of 168 patients

Frédéric Vallot, M. Paesmans, T. Berghmans et al. · Supportive Care in Cancer · 2003 · 23 citations

Medicine, Cancer Management, Independent Predictor +8

A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer

Jean‐Paul Sculier, J.J. Lafitte, J. Lecomte et al. · Annals of Oncology · 2007 · 20 citations · Full text

Oncology, Cisplatin-based Chemotherapy, Phase Iii +10

A meta-analysis of the role of etoposide (VP16) and cisplatin (CDDP) in small cell lung cancer (SCLC) with a methodology assessment

T. Berghmans, Marianne Paesmans, Céline Mascaux et al. · European Journal of Cancer · 1999 · 11 citations

Medicine, Pathology, Methodology Assessment +6